Pharmaceutical access

          By Daniel Lawler Paris, May 30, 2024 (AFP) - More than 300 politicians, health experts and celebrities on Thursday called for US pharmaceutical giant Gilead to allow cheap, generic versions of a promising new HIV drug to be produced so it can reach people in developing countries most affected by the deadly disease. The drug lenacapavir could be a "real game-changer" in the fight against […]